These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12700456)

  • 41. Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis.
    Boeree MJ; Sauvageot D; Banda HT; Harries AD; Zijlstra EE
    Trop Med Int Health; 2005 Aug; 10(8):723-33. PubMed ID: 16045458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi.
    Kumwenda M; Tom S; Chan AK; Mwinjiwa E; Sodhi S; Joshua M; van Lettow M
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1663-9. PubMed ID: 22118175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-referral between voluntary HIV counselling and testing centres and TB services, Maharashtra, India, 2003-2004.
    Shetty PV; Granich RM; Patil AB; Sawant SK; Sahu S; Wares DF; Chauhan LS; Joshi PL
    Int J Tuberc Lung Dis; 2008 Mar; 12(3 Suppl 1):26-31. PubMed ID: 18302819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV.
    Hoffmann CJ; Chaisson RE; Martinson NA
    PLoS One; 2014; 9(1):e83750. PubMed ID: 24421903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strong effects of home-based voluntary HIV counselling and testing on acceptance and equity: a cluster randomised trial in Zambia.
    Fylkesnes K; Sandøy IF; Jürgensen M; Chipimo PJ; Mwangala S; Michelo C
    Soc Sci Med; 2013 Jun; 86():9-16. PubMed ID: 23608089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Compliance in HIV infected adults. Study of opportunistic infection prophylaxis with cotrimoxazole in Ivory Coast].
    Gourvellec G; Anglaret X; Touré S; Huët C; Dakoury-Dogbo N; Lafont S; N'Dri-Yoman T; Chêne G; Salamon R;
    Presse Med; 2004 May; 33(9 Pt 1):595-600. PubMed ID: 15226691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Boonyagars L; Hirunwiwatkul P; Hurst CP
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):338-344. PubMed ID: 28225346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cotrimoxazole is effective as primary prophylaxis for toxoplasmic encephalitis in HIV-infected patients: a case control study.
    Weigel HM; de Vries E; Regez RM; Henrichs JH; Ten Velden JJ; Frissen PH; van der Meer JT
    Scand J Infect Dis; 1997; 29(5):499-502. PubMed ID: 9435040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'Ivoire.
    Mukadi YD; Wiktor SZ; Coulibaly IM; Coulibaly D; Mbengue A; Folquet AM; Ackah A; Sassan-Morokro M; Bonnard D; Maurice C; Nolan C; Kreiss JK; Greenberg AE
    AIDS; 1997 Jul; 11(9):1151-8. PubMed ID: 9233463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes and safety of concomitant nevirapine and rifampicin treatment under programme conditions in Malawi.
    Moses M; Zachariah R; Tayler-Smith K; Misinde D; Foncha C; Manzi M; Bauerfeind A; Mwagomba B; Kwanjana J; Harries AD
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):197-202. PubMed ID: 20074411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV.
    Ku SW; Jiamsakul A; Joshi K; Pasayan MKU; Widhani A; Chaiwarith R; Kiertiburanakul S; Avihingsanon A; Ly PS; Kumarasamy N; Do CD; Merati TP; Nguyen KV; Kamarulzaman A; Zhang F; Lee MP; Choi JY; Tanuma J; Khusuwan S; Sim BLH; Ng OT; Ratanasuwan W; Ross J; Wong WW;
    J Int AIDS Soc; 2019 Mar; 22(3):e25264. PubMed ID: 30924281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of a national HIV voluntary counselling and testing (VCT) campaign on VCT in a rural hospital in Tanzania.
    Mossdorf E; Stoeckle M; Vincenz A; Mwaigomole EG; Chiweka E; Kibatala P; Urassa H; Abdulla S; Elzi L; Tanner M; Furrer H; Hatz C; Battegay M
    Trop Med Int Health; 2010 May; 15(5):567-73. PubMed ID: 20345555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
    Grimwade K; Swingler G
    Cochrane Database Syst Rev; 2003; (2):CD003508. PubMed ID: 12804472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV screening among TB patients and co-trimoxazole preventive therapy for TB/HIV patients in Addis Ababa: facility based descriptive study.
    Denegetu AW; Dolamo BL
    PLoS One; 2014; 9(2):e86614. PubMed ID: 24498278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Provider-initiated HIV testing & counselling in incident tuberculosis cases under National TB Programme conditions at a tertiary care teaching hospital in Tirupati, south India.
    Mohan A; Harikrishna J; Kumar DP; Kumar ND; Sharma PS; Kumar BS; Sarma KVS
    Indian J Med Res; 2017 Dec; 146(6):774-779. PubMed ID: 29664037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi.
    Harries AD; Nyangulu DS; Kang'ombe C; Ndalama D; Glynn JR; Banda H; Wirima JJ; Salaniponi FM; Liomba G; Maher D; Nunn P
    Trans R Soc Trop Med Hyg; 1998; 92(3):343-7. PubMed ID: 9861414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Provider-initiated HIV testing and counselling for TB patients and suspects in Nairobi, Kenya.
    Odhiambo J; Kizito W; Njoroge A; Wambua N; Nganga L; Mburu M; Mansoer J; Marum L; Phillips E; Chakaya J; De Cock KM
    Int J Tuberc Lung Dis; 2008 Mar; 12(3 Suppl 1):63-8. PubMed ID: 18302825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment Options for HIV-Associated Tuberculosis.
    Onyebujoh PC; Ribeiro I; Whalen CC
    J Infect Dis; 2007 Aug; 196 Suppl 1(Suppl 1):S35-45. PubMed ID: 17726832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.